Global Peptic Ulcer Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431608
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca plc.
  • Cadila Healthcare Ltd.
  • Daewoong Pharmaceuticals
  • Eisai Co. Ltd.
  • PharmaKing Co. Ltd.
  • MORE
Peptic Ulcer Drugs Market - Growth, Future Prospects and Competitive Analysis, 2017 - 2025 the global Peptic ulcer drugs market was valued at US$ 4.63 Bn in 2016, and is expected to reach US$ 5.92 Bn by 2025, expanding at a CAGR of 2.8% from 2017 to 2025.

Market Insights

A peptic ulcer is forms of painful sores that develops on the mucosal lining of the stomach, small intestine or lower esophagus, mainly caused by Helicobacter pylori infection and long-term use of aspirin and certain other painkillers. For the purpose of study peptic ulcer drugs market is segmented on the basis of drug class such as antibiotics, proton pump inhibitors (PPIs), H2 receptor antagonists, gastric mucosal protective drugs, antacids and prostaglandin agonists. It is observed that currently, PPIs is major revenue generating segment because these drugs are recommended as a first line treatment for treatment of peptic ulcers caused by H. pylori bacterial infection and NSAIDs, due to its ability to reduce acid secretion. It is studied that, in the base year 2016, North America dominated the peptic ulcer drugs market in terms of revenue and it is anticipated that it will show steady growth during forecast period. According to Centers for Disease Control and Prevention (CDC) peptic ulcer affects more than 6 million population in the United States annually. Factors such as large number of affected population, higher cost of treatment medication, improved diagnostic technique and upsurge in funding by the government agencies in healthcare system are driving the market growth in North America. On the other hand, Asia Pacific will show highest growth rate during forecast period due to changing lifestyle, higher number of affected population, increasing rate of smoking and rising healthcare awareness would expected to drive growth of peptic ulcers drugs market globally.

Market Competition Assessment

The peptic ulcer drugs market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as Abbott Laboratories, AstraZeneca plc, Cadila Healthcare Ltd, Daewoong Pharmaceuticals, Eisai Co. Ltd, PharmaKing Co. Ltd, Taiho Pharmaceutical (A Otsuka Holdings), Takeda Pharmaceutical, Yuhan Corporation and other.

Key Market Movements:
  • Factors such as increase in number of target population, improved diagnostic techniques, easy availability of treatment medication, preferable use of peptic ulcer medication over surgery and over use of painkiller medications are driving the growth of peptic ulcer drugs market globally.
  • Furthermore change in lifestyle such as stress, diet, increase in rate of smocking would assist growth of peptic ulcer drugs market.
  • However, wide availability of generic medication, poor patient compliance to medication in some countries and adverse effects associated with the use of medication which would negatively impacting market growth of peptic ulcer drugs.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca plc.
  • Cadila Healthcare Ltd.
  • Daewoong Pharmaceuticals
  • Eisai Co. Ltd.
  • PharmaKing Co. Ltd.
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Peptic Ulcer Drugs Market Snapshot
2.2 Global Peptic Ulcer Drugs Market, Drug Class
2.3 Global Peptic Ulcer Drugs Market Share, by Geography, 2016 (Value %)

Chapter 3 Peptic Ulcer Drugs Market Analysis
3.1 Global Peptic Ulcer Drugs Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Pipeline Analysis in Peptic Ulcer Drugs Market
3.4 Global Epidemiology Data for Peptic Ulcer
3.5 Attractive Investment Proposition
3.6 Competitive Landscape of Key Players in Peptic Ulcer Drugs Market

Chapter 4 Global Peptic Ulcer Drugs Market, by Drug Class
4.1 Overview
4.2 Top 3 Countries
4.3 Antibiotics
4.4 Proton Pump Inhibitors (PPIs)
4.5 H2 Receptor Antagonists
4.6 Gastric Mucosal Protective Drugs
4.7 Antacids
4.8 Prostaglandin Agonists

Chapter 5 Global Peptic Ulcer Drugs Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.2.1 North America Peptic Ulcer Drugs Market, by Drug Class, 2015- 2025 (US$)
5.2.2 North America Peptic Ulcer Drugs Market, by Country, 2015- 2025 (US$)
5.3 Europe (U.K., Germany & Rest of Europe)
5.3.1 Europe Peptic Ulcer Drugs Market, by Drug Class, 2015- 2025 (US$)
5.3.2 Europe Peptic Ulcer Drugs Market, by Country, 2015- 2025 (US$)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.4.1 Asia Pacific Peptic Ulcer Drugs Market, by Drug Class, 2015- 2025 (US$)
5.4.1 Asia Pacific Peptic Ulcer Drugs Market, by Country, 2015- 2025 (US$)
5.5 Latin America (Brazil, Mexico and Rest of LATAM)
5.5.1 Latin America Peptic Ulcer Drugs Market, by Drug Class, 2015- 2025 (US$)
5.5.2 Latin America Peptic Ulcer Drugs Market, by Country, 2015- 2025 (US$)
5.6 Middle East and Africa (GCC and Rest of MEA)
5.6.1 Middle East and Africa Peptic Ulcer Drugs Market, by Drug Class, 2015- 2025 (US$)
5.6.2 Middle East and Africa Peptic Ulcer Drugs Market, by Country, 2015- 2025 (US$)

Chapter 6 Company Profiles
6.1 Abbott Laboratories
6.2 AstraZeneca plc.
6.3 Cadila Healthcare Ltd.
6.4 Daewoong Pharmaceuticals
6.5 Eisai Co. Ltd.
6.6 PharmaKing Co. Ltd.
6.7 Taiho Pharmaceutical (A Otsuka Holdings)
6.8 Takeda Pharmaceutical
6.9 Yuhan Corporation

List of Figures
Fig. 1 Peptic Ulcer Drugs Market: Research Methodology
Fig. 2 Global Peptic Ulcer Drugs Market, by Drug Class, 2016 (US$ Bn)
Fig. 3 Global Peptic Ulcer Drugs Market Share, by Geography, 2016 (Value %)
Fig. 4 Attractive Investment Proposition: Global Peptic Ulcer Drugs Market, by Geography, 2016
Fig. 5 Global Antibiotics Market in Peptic Ulcer Treatment, 2015 - 2025 (US$ Bn)
Fig. 6 Global Proton Pump Inhibitors (PPIs) Market in Peptic Ulcer Treatment, 2015 - 2025 (US$ Bn)
Fig. 7 Global H2 Receptor Antagonists Market in Peptic Ulcer Treatment, 2015 - 2025 (US$ Bn)
Fig. 8 Global Gastric Mucosal Protective Drugs Market in Peptic Ulcer Treatment, 2015 - 2025 (US$ Bn)
Fig. 9 Global Antacids Market in Peptic Ulcer Treatment, 2015 - 2025 (US$ Bn)
Fig. 10 Global Prostaglandin Agonists Market in Peptic Ulcer Treatment, 2015 - 2025 (US$ Bn)

List of Tables
Table 1 Market Positioning of Key Players in Global Peptic Ulcer Drugs Market
Table 2 Global Peptic Ulcer Drugs Market, by Drug Class, 2015 - 2025 (US$ Bn)
Table 3 Top 3 Countries in Global Peptic Ulcer Drugs Market, 2015 - 2025 (US$ Bn)
Table 4 Global Peptic Ulcer Drugs Market, by Geography, 2015 - 2025 (US$ Bn)
Table 5 North America Peptic Ulcer Drugs Market, by Drug Class, 2015-2025 (US$ Bn)
Table 6 North America Peptic Ulcer Drugs Market, by Country, 2015 - 2025 (US$ Bn)
Table 7 Europe Peptic Ulcer Drugs Market, by Drug Class, 2015-2025 (US$ Bn)
Table 8 Europe Peptic Ulcer Drugs Market, by Country, 2015 - 2025 (US$ Bn)
Table 9 Asia Pacific Peptic Ulcer Drugs Market, by Drug Class, 2015-2025 (US$ Bn)
Table 10 Asia Pacific Peptic Ulcer Drugs Market, by Country, 2015 - 2025 (US$ Bn)
Table 11 Latin America Peptic Ulcer Drugs Market, by Drug Class, 2015-2025 (US$ Bn)
Table 12 Latin America Peptic Ulcer Drugs Market, by Country, 2015 - 2025 (US$ Bn)
Table 13 Middle East and Africa Peptic Ulcer Drugs Market, by Drug Class, 2015-2025 (US$ Bn)
Table 14 Middle East and Africa Peptic Ulcer Drugs Market, by Country, 2015 - 2025 (US$ Bn)
Table 15 Abbott Laboratories: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 16 AstraZeneca plc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 17 Cadila Healthcare Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 18 Daewoong Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 19 Eisai Co. Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 20 PharmaKing Co. Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 21 Taiho Pharmaceutical (A Otsuka Holdings): Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 22 Takeda Pharmaceutical: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 23 Yuhan Corporation: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • AstraZeneca plc.
  • Cadila Healthcare Ltd.
  • Daewoong Pharmaceuticals
  • Eisai Co. Ltd.
  • PharmaKing Co. Ltd.
  • Taiho Pharmaceutical (A Otsuka Holdings)
  • Takeda Pharmaceutical
  • Yuhan Corporation
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll